DarioHealth Corp.
DRIO
$9.14
-$0.06-0.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 27.15M | 28.03M | 27.04M | 23.05M | 19.15M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.15M | 28.03M | 27.04M | 23.05M | 19.15M |
| Cost of Revenue | 8.28M | 8.58M | 8.75M | 9.01M | 8.61M |
| Gross Profit | 18.87M | 19.46M | 18.30M | 14.04M | 10.54M |
| SG&A Expenses | 37.95M | 41.64M | 46.10M | 46.27M | 46.30M |
| Depreciation & Amortization | 3.94M | 4.74M | 5.03M | 4.85M | 4.61M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 68.73M | 76.60M | 84.06M | 83.22M | 82.83M |
| Operating Income | -41.58M | -48.57M | -57.02M | -60.16M | -63.68M |
| Income Before Tax | -44.02M | -44.64M | -44.60M | -49.34M | -52.73M |
| Income Tax Expenses | 164.00K | 164.00K | -1.85M | -1.94M | -1.93M |
| Earnings from Continuing Operations | -44.18 | -44.80 | -42.75 | -47.40 | -50.80 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -44.18M | -44.80M | -42.75M | -47.40M | -50.80M |
| EBIT | -41.58M | -48.57M | -57.02M | -60.16M | -63.68M |
| EBITDA | -35.26M | -41.21M | -49.59M | -53.97M | -57.96M |
| EPS Basic | -13.80 | -11.95 | -13.10 | -18.92 | -23.87 |
| Normalized Basic EPS | -10.90 | -11.90 | -12.80 | -17.51 | -20.52 |
| EPS Diluted | -13.89 | -12.04 | -13.19 | -19.01 | -23.87 |
| Normalized Diluted EPS | -10.90 | -11.90 | -12.80 | -17.51 | -20.52 |
| Average Basic Shares Outstanding | 10.81M | 10.32M | 9.68M | 7.18M | 6.60M |
| Average Diluted Shares Outstanding | 10.81M | 10.32M | 9.68M | 7.18M | 6.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |